Stretch of atrial myocytes stimulates recruitment of macrophages via ATP released through gap-junction channels

Journal of Pharmacological Sciences

Volumn 120, Issue 4, 2012, Pages 296-304

  Oishi, Sakiko ^a   Sasano, Tetsuo ^a,b   Tateishi, Yumiko ^a   Tamura, Noriko ^b   Isobe, Mitsuaki ^b   Furukawa, Tetsushi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ATP; Atrial fibrillation; Gap junction channel; Inflammation; Macrophage

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; CARBENOXOLONE; GAP JUNCTION PROTEIN; PANNEXIN 2; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CELL INFILTRATION; COCULTURE; CONTROLLED STUDY; HEART ATRIUM; HEART MUSCLE CELL; IN VITRO STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN;

EID: 84871516615     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12202FP     Document Type: Article

References (39)

1. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117:1255-1260. (Pubitemid 351365676)
2. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol. 2008;1:62-73.
3. Prasongsukarn K, Abel JG, Jamieson WRE, Cheung A, Russell JA, Walley KR, et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg. 2005;130:93-98. (Pubitemid 40941674)
4. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108:3006-3010. (Pubitemid 37553570)
5. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021.
6. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891. (Pubitemid 33139098)
7. Hagiwara N. Inflammation and atrial fibrillation. Circ J. 2010;74:246-247.
8. Yamashita T, Sekiguchi A, Iwasaki Y-K, Date T, Sagara K, Tanabe H, et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J. 2010;74:262-270.
9. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the framingham study. N Engl J Med. 1982;306:1018-1022. (Pubitemid 12155370)
10. Krahn AD, Manfreda J, Tate RB, Mathewson FAL, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med. 1995;98:476-484.
11. Suzuki T, Yamazaki T, Ogawa S, Nagai R, Yamashita T. Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese rhythm management trial II for atrial fibrillation (J-RHYTHM II Study). Heart Rhythm. 2011;8:1831-1836.
12. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802.
13. Trautmann A. Extracellular ATP in the immune system: more than just a "danger signal". Sci Signal. 2009;2:pe6.
14. Moon H, Na H-Y, Chong KH, Kim TJ. P2x7 receptor-dependent ATP-induced shedding of cd27 in mouse lymphocytes. Immunol Lett. 2006;102:98.
15. Anselmi F, Hernandez VH, Crispino G, Seydel A, Ortolano S, Roper SD, et al. ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear. Proc Natl Acad Sci U S A. 2008; 105:18770-18775.
16. Locovei S, Bao L, Dahl G. Pannexin 1 in erythrocytes: function without a gap. Proc Natl Acad Sci U S A. 2006;103:7655-7659.
17. Nishida M, Sato Y, Uemura A, Narita Y, Tozaki-Saitoh H, Nakaya M, et al. P2Y6 receptor-G[alpha]12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J. 2008;27:3104.
18. Light DB, Capes TL, Gronau RT, Adler MR. Extracellular ATP stimulates volume decrease in Necturus red blood cells. Am J Physiol. 1999;277:C480-C491. (Pubitemid 29458183)
19. Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, et al. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature. 2010;467:863-867.
20. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, et al. Hl-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A. 1998;95: 2979-2984. (Pubitemid 28135840)
21. Yamashiro K, Sasano T, Tojo K, Namekata I, Kurokawa J, Sawada N, et al. Role of transient receptor potential vanilloid 2 in LPS-induced cytokine production in macrophages. Biochem Biophys Res Commun. 2010;398:284-289.
22. Sasano T, McDonald AD, Kikuchi K, Donahue JK. Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med. 2006;12:1256-1258. (Pubitemid 44706927)
23. Liao C-H, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, et al. Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest. 2010;120:242-253.
24. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Col Cardiol. 2003;41:2197-2204. (Pubitemid 36724267)
25. Kienitz M-C, Bender K, Dermietzel R, Pott L, Zoidl G. Pannexin 1 constitutes the large conductance cation channel of cardiac myocytes. J Biol Chem. 2011;286:290-298.
26. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1[beta] release by the ATP-gated P2X7 receptor. EMBO J. 2006;25:5071-5082. (Pubitemid 44658525)
27. Spray DC, Ye Z-C, Ransom BR. Functional connexin "hemichannels" : a critical appraisal. Glia. 2006;54:758-773. (Pubitemid 44629638)
28. Cotrina ML, Kang J, Lin JH-C, Bueno E, Hansen TW, He L, et al. Astrocytic gap junctions remain open during ischemic conditions. J Neurosci. 1998;18:2520-2537. (Pubitemid 28141800)
29. Pearson RA, Dale N, Llaudet E, Mobbs P. ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron. 2005;46:731-744. (Pubitemid 40733129)
30. Zhao H-B, Yu N, Fleming CR. Gap junctional hemichannel-mediated ATP release and hearing controls in the inner ear. Proc Natl Acad Sci U S A. 2005;102:18724-18729. (Pubitemid 43011293)
31. Gomes P, Srinivas SP, Van Driessche W, Vereecke J, Himpens B. ATP release through connexin hemichannels in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2005;46:1208-1218. (Pubitemid 41685855)
32. Uzzaman M, Honjo H, Takagishi Y, Emdad L, Magee AI, Severs NJ, et al. Remodeling of gap junctional coupling in hypertrophied right ventricles of rats with monocrotaline-induced pulmonary hypertension. Circ Res. 2000;86:871-878. (Pubitemid 30246984)
33. Emdad L, Uzzaman M, Takagishi Y, Honjo H, Uchida T, Severs NJ, et al. Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. J Mol Cell Cardiol. 2001;33:219-231. (Pubitemid 32537922)
34. Teunissen BEJ, Jongsma HJ, Bierhuizen MFA. Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J. 2004;25:1979-1989. (Pubitemid 39486016)
35. Bao L, Sachs F, Dahl G. Connexins are mechanosensitive. Am J Physiol Cell Physiol. 2004;287:C1389-C1395. (Pubitemid 39382899)
36. Bikou O, Thomas D, Trappe K, Lugenbiel P, Kelemen K, Koch M, et al. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovasc Res. 2011;92:218-225.
37. Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, et al. Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation / clinical perspective. Circulation. 2012;125:216-225.
38. Howarth FC, Qureshi MA. Effects of carbenoxolone on heart rhythm, contractility and intracellular calcium in streptozotocin-induced diabetic rat. Mol Cell Biochem. 2006;289:21-29. (Pubitemid 44322471)
39. Whitwhorth JA, Williamson PM, Brown MA, Edwards CR. Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment. Clin Exp Hypertens. 1994;16:431-450. (Pubitemid 24225602)